Medtronic (MDT) is undervalued, with strong organic growth and an 11% upside to a $105 target price, supporting a Buy rating.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback